Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of vonoprazan fumarate 20 mg tablets under fasting and fed conditions in healthy Chinese subjects
CTR20244239Phase 2Completed
- Sponsor
- Jinan Mingxin Pharmaceutical
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vonoprazan in gastroesophageal reflux disease (GERD), erosive esophagitis (EE), sponsored by Jinan Mingxin Pharmaceutical. Started Nov 2024; status: completed.
02
Drugs
vonoprazan
03
Conditions
gastroesophageal reflux disease (GERD)erosive esophagitis (EE)
Beyond the preview
Go deeper on CTR20244239.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20244239.